Humana to Acquire Enclara Healthcare

Go back to Humana to Acquire Enclara Healthcare

SunTrust Reiterates Hold Rating on Humana (HUM) Following Announced Enclara Acquisition

December 17, 2019 7:53 AM EST

SunTrust analyst David MacDonald reiterated a Hold rating and $370.00 price target on Humana (NYSE: HUM) following the company's announced entry into a definitive agreement to acquire Enclara Healthcare. The deal is expected to close in 1H 2020.

MacDonald views the deal as a nice... More